Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
IonDX
company
About
IonDX is a bioanalytical instrumentation company commercializing an advanced system to analyze biologic drugs.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $225K
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
IonDX is a bioanalytical instrumentation company commercializing an advanced system to analyze biologic drugs. It leverages the expertise of founding members who have over 40 years of experience developing analytical instrumentation for biomacromolecules and nanomaterials. The company's innovative and patented ion mobility technology aims to help scientists analyze the higher order structure of proteins and biotherapeutics in a high throughput manner.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$1.12M
IonDX has raised a total of
$1.12M
in funding over 2 rounds. Their latest funding was raised on
Sep 10, 2019 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 10, 2019 | Grant | $898.36K | 1 |
National Science Foundation
|
— | Detail |
| Jun 14, 2018 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
IonDX is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
